NL6716791A - - Google Patents

Info

Publication number
NL6716791A
NL6716791A NL6716791A NL6716791A NL6716791A NL 6716791 A NL6716791 A NL 6716791A NL 6716791 A NL6716791 A NL 6716791A NL 6716791 A NL6716791 A NL 6716791A NL 6716791 A NL6716791 A NL 6716791A
Authority
NL
Netherlands
Application number
NL6716791A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6716791A publication Critical patent/NL6716791A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/48—Polyethers
    • C08G18/487—Polyethers containing cyclic groups
    • C08G18/4883—Polyethers containing cyclic groups containing cyclic groups having at least one oxygen atom in the ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/01—Wetting, emulsifying, dispersing, or stabilizing agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Paper (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NL6716791A 1966-12-16 1967-12-11 NL6716791A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60214566A 1966-12-16 1966-12-16

Publications (1)

Publication Number Publication Date
NL6716791A true NL6716791A (fr) 1968-06-17

Family

ID=24410151

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6716791A NL6716791A (fr) 1966-12-16 1967-12-11

Country Status (5)

Country Link
US (1) US3459731A (fr)
BE (1) BE707947A (fr)
FR (1) FR1548917A (fr)
GB (1) GB1193197A (fr)
NL (1) NL6716791A (fr)

Families Citing this family (216)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6026493B2 (ja) * 1980-01-29 1985-06-24 静岡大学長 ポリエーテルカーボネート
AU544564B2 (en) * 1980-08-09 1985-06-06 Sato Shokuhin Kogyo Kabushiki Kaisha Extracting beverages using cyclodextrin
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
EP0146841A3 (fr) * 1983-12-17 1986-11-20 Consortium für elektrochemische Industrie GmbH Ether mixte de bêta-cyclodextrine soluble dans l'eau et procédé pour sa préparation
DE3477929D1 (en) * 1983-12-17 1989-06-01 Hoechst Ag Beta-cyclodextrin and process for its preparation
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US4870060A (en) * 1985-03-15 1989-09-26 Janssen Pharmaceutica Derivatives of γ-cylodextrin
US6407079B1 (en) * 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
US4920214A (en) * 1986-04-16 1990-04-24 American Maize-Products Company Process for producing modified cyclodextrins
IT1203968B (it) * 1987-04-24 1989-02-23 Bononi Ricerca Complessi di b-ciclodestrina ad attivita' antimicotica
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US4889634A (en) * 1988-10-04 1989-12-26 Gynex, Inc. Dialysate solution containing hydroxypropyl-beta-cyclodextrin and method of using same
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
AU616571B2 (en) * 1988-10-28 1991-10-31 Shiseido Company Ltd. Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
US5096893A (en) * 1989-04-03 1992-03-17 The United States Of America As Represented By The Department Of Health And Human Services Regioselective substitutions in cyclodextrins
ATE166884T1 (de) * 1989-04-03 1998-06-15 Janssen Pharmaceutica Nv Regioselektive substitutionen von cyclodextrinen
US5173481A (en) * 1989-04-03 1992-12-22 The United States Of America As Represented By The Department Of Health And Human Services Preparation of specifically substituted cyclodextrins
US5064944A (en) * 1989-09-12 1991-11-12 Advanced Separation Technologies Inc. Chiral separation media
US5154738A (en) * 1989-09-12 1992-10-13 Advanced Separation Technologies, Inc. Chiral separation media
US4948395A (en) * 1989-09-12 1990-08-14 Advanced Separations Technologies Inc. Chiral separation media
US5063251A (en) * 1990-05-04 1991-11-05 American Maize-Products Company Blowing and curing of resins and plastics materials with cyclodextrin complexes
US5258414A (en) * 1990-05-04 1993-11-02 American Maize Technology, Inc. Adhesives and sealants
US5352717A (en) * 1990-05-04 1994-10-04 American Maize Technology Inc. Adhesives and sealants
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5238927A (en) * 1990-11-30 1993-08-24 Brown Nesbitt D Hydrolytic stabilizer for unstable organic ions
NZ244424A (en) * 1991-09-23 1995-03-28 American Maize Prod Co Adhesive composition comprising plastics material, cyclodextrin and a blowing agent; method of increasing adhesive nature of composition
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5684169A (en) * 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use
TW349870B (en) * 1993-09-30 1999-01-11 Janssen Pharmaceutica Nv An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
US5534165A (en) * 1994-08-12 1996-07-09 The Procter & Gamble Company Fabric treating composition containing beta-cyclodextrin and essentially free of perfume
AU3242995A (en) 1994-08-12 1996-03-07 Procter & Gamble Company, The Composition for reducing malodor impression on inanimate surfaces
US5578563A (en) * 1994-08-12 1996-11-26 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US5939060A (en) * 1994-08-12 1999-08-17 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
US5714137A (en) * 1994-08-12 1998-02-03 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
US5593670A (en) * 1994-08-12 1997-01-14 The Proctor & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
US5663134A (en) * 1994-08-12 1997-09-02 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US5670475A (en) * 1994-08-12 1997-09-23 The Procter & Gamble Company Composition for reducing malodor impression of inanimate surfaces
US5492615A (en) * 1994-11-22 1996-02-20 Learonal Inc. Cyclodextrin stabilization of organic metal finishing additives in aqueous metal treating baths
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5744154A (en) * 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
WO1997039761A1 (fr) 1996-04-19 1997-10-30 Alpha Therapeutic Corporation Procede d'inactivation de virus dans des proteines sanguines lyophilisees
UA57734C2 (uk) * 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
US5874067A (en) * 1996-10-24 1999-02-23 The Procter & Gamble Company Methods for controlling environmental odors on the body
US5911976A (en) * 1996-10-24 1999-06-15 The Procter & Gamble Company Compositions for reducing body odor
US5879666A (en) * 1996-10-24 1999-03-09 The Procter & Gamble Company Methods and compositions for reducing body odor
US5882638A (en) * 1996-10-24 1999-03-16 The Proctor & Gamble Company Methods using uncomplexed cyclodextrin solutions for controlling environmental odors
US5897855A (en) * 1996-10-24 1999-04-27 The Procter & Gamble Company Methods and compositions for reducing body odor
US5780020A (en) * 1996-10-28 1998-07-14 The Proctor & Gamble Company Methods and compositions for reducing body odor
US5885599A (en) * 1996-10-28 1999-03-23 The Procter & Gamble Company Methods and compositions for reducing body odors and excess moisture
US20060029653A1 (en) 1997-01-29 2006-02-09 Cronk Peter J Therapeutic delivery system
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
ES2324378T3 (es) * 1998-02-05 2009-08-05 Novartis Ag Composicion farmaceutica que contiene epotilona.
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
BRPI9915552B8 (pt) 1998-11-10 2021-05-25 Janssen Pharmaceutica Nv pirimidinas inibidoras da reprodução do hiv
US6358469B1 (en) 1998-12-01 2002-03-19 S. C. Johnson & Son, Inc. Odor eliminating aqueous formulation
CA2371940C (fr) * 1999-03-31 2008-07-15 Janssen Pharmaceutica N.V. Amidon pregelatinise dans une formulation a liberation regulee
ID30409A (id) 1999-05-04 2001-11-29 Jannsen Pharmaceutica N V Eter anti jamur
DE19928676A1 (de) * 1999-06-23 2000-12-28 Basf Ag Polyisocyanat-Polyadditionsprodukte
DE19930553A1 (de) * 1999-07-02 2001-01-11 Wacker Chemie Gmbh Verfahren zur Herstellung von alkylierten Cyclodextrin-Derivaten
US6764986B1 (en) 1999-07-08 2004-07-20 Procter & Gamble Company Process for producing particles of amine reaction products
US6740713B1 (en) 1999-07-08 2004-05-25 Procter & Gamble Company Process for producing particles of amine reaction products
US6972276B1 (en) 1999-07-09 2005-12-06 Procter & Gamble Company Process for making amine compounds
AU7986400A (en) 1999-09-27 2001-04-30 Procter & Gamble Company, The Hard surface cleaning compositions, premoistened wipes, methods of use, and articles comprising said compositions or wipes and instructions for use resulting ineasier cleaning and maintenance, improved surface appearance and/or hygiene und er stress conditions such as no-rinse
US6716805B1 (en) * 1999-09-27 2004-04-06 The Procter & Gamble Company Hard surface cleaning compositions, premoistened wipes, methods of use, and articles comprising said compositions or wipes and instructions for use resulting in easier cleaning and maintenance, improved surface appearance and/or hygiene under stress conditions such as no-rinse
US20050133174A1 (en) * 1999-09-27 2005-06-23 Gorley Ronald T. 100% synthetic nonwoven wipes
US6479467B1 (en) * 1999-12-16 2002-11-12 Eastman Chemical Company Cyclodextrin ethers
EP1261607B1 (fr) 2000-03-01 2008-11-12 Janssen Pharmaceutica N.V. Derives de thiazolyle 2,4-disubstitue
EP1282606B1 (fr) 2000-05-08 2015-04-22 Janssen Pharmaceutica NV Inhibiteurs de la replication du vih
US20020169090A1 (en) * 2000-07-19 2002-11-14 Foley Peter Robert Cleaning composition
ATE278764T1 (de) * 2000-07-19 2004-10-15 Procter & Gamble Reinigungsmittelzusammensetzungen
US7645746B1 (en) 2000-11-13 2010-01-12 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
US7074824B2 (en) * 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US8101629B2 (en) * 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
CN100496493C (zh) 2001-08-13 2009-06-10 詹森药业有限公司 2-氨基-4,5-三取代噻唑基衍生物
US7638522B2 (en) * 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
OA12790A (en) 2002-03-13 2006-07-10 Janssen Pharmaceutica Nv New inhibitors of histone deacetylase.
MXPA04007776A (es) 2002-03-13 2004-10-15 Janssen Pharmaceutica Nv Derivados de sulfonilamino como nuevos inhibidores de histona deacetilasa.
BR0308475A (pt) * 2002-03-20 2005-01-11 Pharmacia Corp Formulação de eplerenona estável na armazenagem
DE10215942A1 (de) * 2002-04-11 2003-10-23 Bayer Ag Wässrige Formulierungen von (2-Hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorbutan-1-sulfonat
WO2003097011A1 (fr) * 2002-05-17 2003-11-27 Eisai Co., Ltd. Compositions et methodes utilisant des inhibiteurs de la pompe a protons
US20030224030A1 (en) 2002-05-23 2003-12-04 Hirotaka Uchiyama Methods and articles for reducing airborne particulates
US6710096B2 (en) 2002-07-22 2004-03-23 Basf Corporation Polyether polyol for foam applications
CN100554245C (zh) * 2002-08-09 2009-10-28 詹森药业有限公司 制备4-[[4-[[4-(2-氰基乙烯基)-2,6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的方法
WO2004074266A1 (fr) 2003-02-07 2004-09-02 Janssen Pharmaceutica N.V. 1,2,4-triazines inhibant le vih
CA2513527C (fr) * 2003-02-07 2012-08-14 Janssen Pharmaceutica N.V. Derives de pyrimidine utilises dans la prevention des infections par le vih
CL2004000303A1 (es) * 2003-02-20 2005-04-08 Tibotec Pharm Ltd Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
ES2584183T3 (es) * 2003-03-28 2016-09-26 Ares Trading S.A. Formulaciones de cladribina para suministro mejorado oral y transmucosa
PL1608344T3 (pl) * 2003-03-28 2011-01-31 Ares Trading Sa Doustne formulacje kladrybiny
US7157446B2 (en) 2003-05-02 2007-01-02 Bristol Myers Squibb Company Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
ES2905724T3 (es) 2003-06-13 2022-04-11 Alnylam Europe Ag Acido ribonucleico bicatenario con elevada eficacia en un organismo
UA81305C2 (en) 2003-07-02 2007-12-25 Ares Trading Sa Formulation of cladribine (variants), cladribine-cyclodextrin complex, use of cladribine-cyclodextrin complex, mixture
US20050059645A1 (en) * 2003-07-31 2005-03-17 Bodor Nicholas S. Methods for the treatment of male and female sexual dysfunction
CN100475815C (zh) * 2003-09-25 2009-04-08 詹森药业有限公司 抑制hiv复制的嘌呤衍生物
ES2515092T3 (es) 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
EP2610234A1 (fr) 2004-02-24 2013-07-03 The General Hospital Corporation Radiofluoration catalytique
US20050234018A1 (en) * 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
EP3034510A1 (fr) 2004-04-30 2016-06-22 Alnylam Pharmaceuticals Inc. Oligonucléotides comprenant une pyrimidine modifiée c5
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
US7151121B2 (en) * 2004-05-26 2006-12-19 Danisco A/S Polyurethane containing a polyol composition comprising a highly branched polysaccharide, mix and process for preparation thereof
BRPI0511070A (pt) 2004-06-17 2007-11-27 Infinity Pharmaceuticals Inc compostos e processos para inibição da interação de proteìnas bcl com parceiros de ligação
WO2006010750A1 (fr) 2004-07-28 2006-02-02 Janssen Pharmaceutica N.V. Derives d'indolyl alkyl amine substitues utilises en tant que nouveaux inhibiteurs d'histone deacetylase
US7923554B2 (en) * 2004-08-10 2011-04-12 Janssen Pharmaceutica N.V. HIV inhibiting 1,2,4-triazin-6-one derivatives
CN101027288B (zh) * 2004-09-30 2013-04-17 泰博特克药品有限公司 抑制hiv的5-取代嘧啶
AU2005288864B2 (en) * 2004-09-30 2012-08-23 Janssen Sciences Ireland Uc HIV inhibiting 5-heterocyclyl pyrimidines
CA2577588C (fr) 2004-10-29 2013-09-10 Tibotec Pharmaceuticals Ltd. Derives de pyrimidine bicycliques inhibant le vih
CN101107234B (zh) 2005-01-27 2013-06-19 泰博特克药品有限公司 抑制hiv的2-(4-氰基苯氨基)嘧啶衍生物
CN101287468A (zh) * 2005-02-18 2008-10-15 表面线段公司 制备包含官能性残基或基团的药动学改善的化合物的方法以及包含所述化合物的药用组合物
EP1850853A4 (fr) * 2005-02-18 2011-09-07 Surface Logix Inc Composes presentant des proprietes pharmacocinetiques ameliorees
DE602006015291D1 (de) * 2005-03-04 2010-08-19 Little Island Co Cork Hiv-inhibierende 2-(4-cyanophenyl)-6-hydroxylaminopyrimidine
WO2006124726A2 (fr) * 2005-05-12 2006-11-23 The General Hospital Corporation Nouvelles compositions biotinylatees
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
EP1928464B1 (fr) 2005-09-30 2014-05-14 Lundbeck Inc. Nouvelle preparation a base de carbamazepine a administration par voie parenterale
US20070098148A1 (en) * 2005-10-14 2007-05-03 Sherman Kenneth N Aroma releasing patch on mobile telephones
WO2007082874A1 (fr) 2006-01-19 2007-07-26 Janssen Pharmaceutica N.V. Dérivés de pyridine et de pyrimidine en tant qu'inhibiteurs d'histone désacétylase
JP5137849B2 (ja) * 2006-01-19 2013-02-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼのインヒビターとしての置換インドリル−アルキル−アミノ−誘導体
DK1981874T3 (da) * 2006-01-19 2009-09-28 Janssen Pharmactuica N V Aminophenylderivater som nye inhibitorer af histondeacetylase
CN101410394B (zh) * 2006-03-30 2012-02-08 泰博特克药品有限公司 抑制人免疫缺陷病毒的5-(羟基亚甲基和氨基亚甲基)取代的嘧啶
EP2004632B1 (fr) 2006-03-30 2014-03-12 Janssen R&D Ireland Pyrimidines à substitution 5-amido inhibant le vih
EP2054386B1 (fr) 2006-08-03 2014-10-08 Trustees Of Tufts College Analogues de la niacine sans effets de bouffées congestives et procédés d'utilisation
RU2009111263A (ru) 2006-08-30 2010-10-10 Дэвид Уилльям СМИТ (US) Способ придания одноосевой или многоосевой жесткости экструдированным материалам, а также изделия, получаемые из них
EP1920785A1 (fr) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine
BRPI0720858B8 (pt) * 2006-12-29 2021-05-25 Janssen R & D Ireland pirimidinas 6-substituídas inibidoras de hiv e composição farmacêutica que as compreende
AU2007341228B2 (en) * 2006-12-29 2013-04-18 Janssen Sciences Ireland Uc HIV inhibiting 5,6-substituted pyrimidines
WO2008088816A1 (fr) * 2007-01-18 2008-07-24 Pgxhealth, Llc Formulations de dérivé d'adénosine pour l'imagerie médicale
NZ582254A (en) * 2007-06-28 2012-07-27 Buckman Labor Inc Use of cyclodextrins for odor control in papermaking sludges, and deodorized sludge and products
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US8845627B2 (en) 2008-08-22 2014-09-30 Boston Scientific Scimed, Inc. Regulating pressure to lower temperature in a cryotherapy balloon catheter
EP2350281B1 (fr) 2008-10-24 2014-05-14 Sarepta Therapeutics, Inc. Compositions à sauts d'exons multiples pour la dmd
MY161597A (en) 2008-11-15 2017-04-28 Rib-X Pharmaceuticals Inc Antimicrobial compositions
EP2216394A1 (fr) 2009-01-30 2010-08-11 The Procter & Gamble Company Procédé pour parfumer des étoffes
US9701177B2 (en) 2009-04-02 2017-07-11 Henkel Ag & Co. Kgaa Ceramic coated automotive heat exchanger components
WO2011060320A1 (fr) 2009-11-13 2011-05-19 Avi Biopharma, Inc. Composé antiviral antisens et méthode de traitement d'une infection par le virus grippal
EP2545173A2 (fr) 2010-03-12 2013-01-16 Sarepta Therapeutics, Inc. Modulation anti-sens de récepteurs hormonaux nucléaires
ES2816898T3 (es) 2010-05-13 2021-04-06 Sarepta Therapeutics Inc Compuestos que modulan la actividad de señalización de las interleucinas 17 y 23
WO2011163612A1 (fr) 2010-06-24 2011-12-29 Trustees Of Tufts College Mimétiques de niacine et leurs procédés d'utilisation
AU2011270726C1 (en) 2010-06-24 2016-02-18 Arisaph Pharmaceuticals, Inc. Niacin mimetics, and methods of use thereof
US10463687B2 (en) 2011-01-20 2019-11-05 Cornell University Treatments for retinal disorders
EP2667901A1 (fr) 2011-01-27 2013-12-04 Givaudan SA Compositions
EP2732035A2 (fr) 2011-07-15 2014-05-21 Sarepta Therapeutics, Inc. Procédés et compositions pour manipulation de la traduction d'isoformes de protéines à partir de sites initiateurs alternatifs d'initiation
JP6132849B2 (ja) 2011-12-08 2017-05-31 サレプタ セラピューティクス， インコーポレイテッド ヒトｌｍｎａを標的とするオリゴヌクレオチド類似体を使用する早老性ラミノパシーを処置するための方法
JP2015503516A (ja) 2011-12-23 2015-02-02 ノバルティス アーゲー Ｂｃｌ２と結合相手の相互作用を阻害するための化合物
AU2012355613A1 (en) 2011-12-23 2014-07-17 Novartis Ag Compounds for inhibiting the interaction of BCL2 with binding partners
EP2794592A1 (fr) 2011-12-23 2014-10-29 Novartis AG Composés inhibiteurs de l'interaction entre bcl2 et des partenaires de liaison
EP2794591A1 (fr) 2011-12-23 2014-10-29 Novartis AG Composés inhibiteurs de l'interaction entre bcl2 et des partenaires de liaison
JP2015503517A (ja) 2011-12-23 2015-02-02 ノバルティス アーゲー Ｂｃｌ２と結合相手の相互作用を阻害するための化合物
JP6508944B2 (ja) 2012-02-15 2019-05-08 サイデックス・ファーマシューティカルズ・インコーポレイテッド シクロデキストリン誘導体のための製造方法
CA2865950C (fr) 2012-02-28 2016-12-20 Cydex Pharmaceuticals, Inc. Compositions de cyclodextrine alkylee et procedes pour leur preparation et leur utilisation
MX2014013373A (es) 2012-05-15 2015-08-14 Novartis Ag Derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1.
KR20150008406A (ko) 2012-05-15 2015-01-22 노파르티스 아게 Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 벤즈아미드 유도체
AP3613A (en) 2012-05-15 2016-02-29 Novartis Ag Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 abl1abl2 bcr-abl1
PT2900637T (pt) 2012-05-15 2017-11-15 Novartis Ag Derivados de amida de pirimidina, piridina e pirazina substituídos com tiazole ou imidazole e compostos relacionados como inibidores de abl1, abl2 e bcr-abl1 para tratamento do cancro, infecções virais específicas e disturbios do snc específicos
WO2014036427A1 (fr) 2012-08-31 2014-03-06 The General Hospital Corporation Complexes de biotine pour le traitement et le diagnostic de la maladie d'alzheimer
MX360192B (es) 2012-10-22 2018-10-24 Cydex Pharmaceuticals Inc Composiciones de ciclodextrinas alquiladas y procesos para preparar y usar las mismas.
AU2013364158A1 (en) 2012-12-20 2015-07-09 Sarepta Therapeutics, Inc. Improved exon skipping compositions for treating muscular dystrophy
HUE039052T2 (hu) 2013-02-19 2018-12-28 Novartis Ag Benzotiofénszármazékok és azok készítményei szelektív ösztrogén receptor lebontóként
CN110066793A (zh) 2013-03-14 2019-07-30 萨勒普塔医疗公司 用于治疗肌肉萎缩的外显子跳跃组合物
BR122020016865B1 (pt) 2013-03-14 2022-12-27 Sarepta Therapeutics, Inc. Oligonucleotídeo antisenso, composição farmacêutica compreendendo o mesmo e uso da dita composição para o tratamento de distrofia muscular de duchenne (dmd)
CA2906812A1 (fr) 2013-03-15 2014-09-18 Sarepta Therapeutics, Inc. Compositions ameliorees pour le traitement de la dystrophie musculaire
KR102455648B1 (ko) 2013-07-19 2022-10-19 베링거잉겔하임베트메디카게엠베하 보존된 에테르화된 사이클로덱스트린 유도체 함유 액체 수성 약제학적 조성물
US9227969B2 (en) 2013-08-14 2016-01-05 Novartis Ag Compounds and compositions as inhibitors of MEK
WO2015022663A1 (fr) 2013-08-14 2015-02-19 Novartis Ag Composés et compositions utiles comme inhibiteurs de mek
WO2015022664A1 (fr) 2013-08-14 2015-02-19 Novartis Ag Composés et compositions utiles comme inhibiteurs de mek
US20150104348A1 (en) 2013-10-10 2015-04-16 The Iams Company Pet Deodorizing Composition
WO2015092634A1 (fr) 2013-12-16 2015-06-25 Novartis Ag Composés et compositions de 1,2,3,4-tétrahydroisoquinoléine en tant qu'antagonistes et agents de dégradation sélectifs des récepteurs des œstrogènes
JO3517B1 (ar) 2014-01-17 2020-07-05 Novartis Ag ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
US10093646B2 (en) 2014-01-17 2018-10-09 Novartis Ag 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
JP6473457B2 (ja) 2014-01-17 2019-02-20 ノバルティス アーゲー Ｓｈｐ２の活性を阻害するための１−（トリアジン−３−イル／ピリダジン−３−イル）−ピペリジン／ピペラジン誘導体およびその組成物
US10851184B2 (en) 2014-08-22 2020-12-01 Cydex Pharmaceuticals, Inc. Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
BR112017013601A2 (pt) 2014-12-23 2018-03-06 Lubrizol Advanced Mat Inc composição detergente líquida, transparente ou translúcida capaz de suspender de forma estável materiais particulados.
CN107257846A (zh) 2014-12-23 2017-10-17 路博润先进材料公司 用与两亲型交联剂交联的两亲型流变改性剂稳定化的衣物洗涤剂组合物
BR112017022524B1 (pt) 2015-04-20 2022-06-14 Cornell University Material polimérico mesoporoso, composição, métodos para purificar uma amostra de fluido, para determinar a presença ou ausência de compostos em uma amostra de fluido, para remover compostos de uma amostra de fluido, para preparar um material polimérico poroso e uma composição, e, artigo de fabricação
WO2016203405A1 (fr) 2015-06-19 2016-12-22 Novartis Ag Composés et compositions pour inhiber l'activité de shp2
CN112625028A (zh) 2015-06-19 2021-04-09 诺华股份有限公司 用于抑制shp2活性的化合物和组合物
EP3310779B1 (fr) 2015-06-19 2019-05-08 Novartis AG Composés et compositions pour l'inhibition de l'activité de shp2
CN108738310A (zh) 2015-09-30 2018-11-02 萨勒普塔医疗公司 用于治疗肌营养不良的方法
EA201892467A1 (ru) 2016-04-29 2019-05-31 Сарепта Терапьютикс, Инк. Олигонуклеотидные аналоги, нацеленные на lmna человека
EA036446B1 (ru) 2016-06-14 2020-11-11 Новартис Аг Соединения и композиции для подавления активности shp2
MA45618A (fr) 2016-06-30 2019-05-08 Sarepta Therapeutics Inc Sauts d'exons oligomères pour la dystrophie musculaire
KR102568036B1 (ko) 2016-08-02 2023-08-17 버지니아 커먼웰스 유니버시티 염증성 피부 질환 및 피부 병변을 치료하기 위한 산소첨가된 콜레스테롤 술페이트 (ocs) 의 용도
EP4101861A1 (fr) 2016-08-02 2022-12-14 Virginia Commonwealth University Compositions comprenant du 5-cholestène-3, 25-diol,3-sulfate (25 h3s) ou un sel pharmaceutiquement acceptable de celui-ci et au moins un oligosaccharide cyclique
SG10202100491QA (en) 2016-12-19 2021-02-25 Sarepta Therapeutics Inc Exon skipping oligomer conjugates for muscular dystrophy
HUE059843T2 (hu) 2016-12-19 2023-01-28 Sarepta Therapeutics Inc Exonátugró oligomerkonjugátumok izomdisztrófiára
CN110636866A (zh) 2016-12-19 2019-12-31 萨勒普塔医疗公司 用于肌肉萎缩症的外显子跳跃寡聚体缀合物
WO2018195338A1 (fr) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions et procédés pour le traitement d'inflammation pulmonaire
CN110831981B (zh) 2017-05-04 2022-06-24 路博润先进材料公司 双活化微凝胶
EA201991450A1 (ru) 2017-09-22 2019-12-30 Сарепта Терапьютикс, Инк. Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии
JP2020536058A (ja) 2017-09-28 2020-12-10 サレプタ セラピューティクス， インコーポレイテッド 筋ジストロフィーを処置するための併用療法
WO2019067975A1 (fr) 2017-09-28 2019-04-04 Sarepta Therapeutics, Inc. Polythérapies pour traiter une dystrophie musculaire
US20200254002A1 (en) 2017-09-28 2020-08-13 Sarepta Therapeutics, Inc. Combination therapies for treating muscular dystrophy
US10758629B2 (en) 2018-05-29 2020-09-01 Sarepta Therapeutics, Inc. Exon skipping oligomer conjugates for muscular dystrophy
EP4219717A3 (fr) 2018-06-13 2023-12-20 Sarepta Therapeutics, Inc. Oligomères à saut d'exon pour la dystrophie musculaire
TW202020153A (zh) 2018-07-27 2020-06-01 美商薩羅塔治療公司 用於肌肉萎縮症之外顯子跳躍寡聚物
WO2020123574A1 (fr) 2018-12-13 2020-06-18 Sarepta Therapeutics, Inc. Conjugués oligomères à saut d'exon pour dystrophie musculaire
CN113490691A (zh) 2019-01-03 2021-10-08 劣势者药物有限公司 环糊精二聚体、其组合物及其用途
US11001645B2 (en) 2019-02-14 2021-05-11 Cyclopure, Inc. Charge-bearing cyclodextrin polymeric materials and methods of making and using same
KR20230169384A (ko) 2019-02-14 2023-12-15 사이클로퓨어, 인코포레이티드 전하 담지 시클로덱스트린 중합체 물질 및 그의 제조 방법 및 사용 방법
JP2022526763A (ja) 2019-03-28 2022-05-26 サレプタ セラピューティクス， インコーポレイテッド カシメルセンによる筋ジストロフィーの治療方法
EP3955966A1 (fr) 2019-04-18 2022-02-23 Sarepta Therapeutics, Inc. Compositions pour le traitement de la dystrophie musculaire
JP2022536495A (ja) 2019-06-19 2022-08-17 サレプタ セラピューティクス， インコーポレイテッド 筋ジストロフィーを治療する方法
WO2021102080A1 (fr) 2019-11-19 2021-05-27 Lubrizol Advanced Materials, Inc. Polymères inhibiteurs de redéposition et compositions détergentes les contenant
CN114867831A (zh) 2019-12-19 2022-08-05 路博润先进材料公司 再沉积抑制性聚合物和含有所述再沉积抑制性聚合物的洗涤剂组合物
EP4233837A1 (fr) 2022-02-24 2023-08-30 CellAct Pharma GmbH Compositions solides et orales de toniribate d'étoposide
WO2023178230A1 (fr) 2022-03-17 2023-09-21 Sarepta Therapeutics, Inc. Conjugués d'oligomère morpholino phosphorodiamidate
CN115322358A (zh) * 2022-08-18 2022-11-11 上海东大化学有限公司 基于环糊精的聚醚多元醇的合成方法
WO2024073570A1 (fr) 2022-09-28 2024-04-04 Altos Labs, Inc. Expression de facteurs de régénération dans des cellules âgées/sénescentes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2518135A (en) * 1946-11-01 1950-08-08 Univ Ohio State Res Found Uniformly 2-substituted glucopyranose polymers
US2996551A (en) * 1953-09-24 1961-08-15 Petrolite Corp Certain polyepoxide-modified oxyalkylation derivatives being obtained in turn by oxyalkylation of certain polyols having at least three hydroxyls
US2761247A (en) * 1953-12-10 1956-09-04 Du Pont Process for conditioning soil with polysaccharide xanthates
US2945025A (en) * 1954-05-24 1960-07-12 Petrolite Corp Certain oxyalkylated glucoses
US2900268A (en) * 1956-11-15 1959-08-18 John C Rankin Process for preparing hydroxyalkylated cereal flour
US3042666A (en) * 1958-02-26 1962-07-03 Ici Ltd Polyether derivatives

Also Published As

Publication number Publication date
FR1548917A (fr) 1968-12-06
BE707947A (fr) 1968-06-14
US3459731A (en) 1969-08-05
GB1193197A (en) 1970-05-28

Similar Documents

Publication Publication Date Title
FR1548917A (fr)
AT281852B (fr)
AU5917865A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU421822B2 (fr)
AU417216B2 (fr)
AU433222B2 (fr)
AU415165B1 (fr)
AU414526B2 (fr)
AU1111066A (fr)
AU5895065A (fr)
AU1144366A (fr)
AU612166A (fr)
AU218666A (fr)
BE693315A (fr)
AU411645B2 (fr)
BE694333A (fr)
AU407778B2 (fr)
BE693524A (fr)
AU2390066A (fr)
BE637138A (fr)
BE693141A (fr)
BE693053A (fr)
BE692748A (fr)